Stay updated on Pembrolizumab Combo in Ovarian Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab Combo in Ovarian Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab Combo in Ovarian Cancer Clinical Trial page

  1. Check
    7 days ago
    No Change Detected
  2. Check
    14 days ago
    No Change Detected
  3. Check
    21 days ago
    Change Detected
    Summary
    The page now displays Revision: v3.3.2, replacing Revision: v3.2.0. This is a minor version update and does not change the study information.
    Difference
    0.1%
    Check dated 2025-11-25T14:49:50.000Z thumbnail image
  4. Check
    29 days ago
    Change Detected
    Summary
    Removed the government funding operating-status notice from the page. The study details and other content remain unchanged.
    Difference
    0.4%
    Check dated 2025-11-18T07:31:56.000Z thumbnail image
  5. Check
    50 days ago
    Change Detected
    Summary
    Only non-substantive updates are visible, such as the last update timestamp; the core study details, eligibility criteria, endpoints, and listed locations appear unchanged.
    Difference
    0.4%
    Check dated 2025-10-27T21:04:41.000Z thumbnail image
  6. Check
    72 days ago
    Change Detected
    Summary
    Major upgrade: version bumped to v3.2.0 and a prominent funding/operating-status notice added; previous v3.1.0 deletion indicates update to the site’s status messaging.
    Difference
    3%
    Check dated 2025-10-06T08:22:45.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    Major update to page status and versioning: add Results Submitted, Last Update Posted (Estimated), and Revision v3.1.0; remove No Results Posted, Last Update Posted, and Revision v3.0.2, plus the ovarian cancer resource reference.
    Difference
    0.6%
    Check dated 2025-09-29T04:57:51.000Z thumbnail image
  8. Check
    86 days ago
    Change Detected
    Summary
    Summary of changes: added several future dates and a note about U.S. manufacturing/export; removed several older dates; overall shift highlights origin and new dates.
    Difference
    1%
    Check dated 2025-09-22T02:43:12.000Z thumbnail image

Stay in the know with updates to Pembrolizumab Combo in Ovarian Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab Combo in Ovarian Cancer Clinical Trial page.